glp-1-directed nmda receptor antagonism for obesity treatment Caveolae with GLP-1 and Receptors as Crossfire Points the Innovative of Cognitive Dysfunction Associated with Neurodegenerative Diseases GLP−1 receptor agonists for the

Recently, many people using GLP-1 medications also report what has been termed Ozempic teeth. According to Catrise Austin, DDS, a cosmetic dentist, author of Stop Diabetes Today, and host of the Lets Talk Smiles Podcast, as more people turn to medications like Ozempic and Wegovy (semaglutide) for diabetes and weight loss, dentists are seeing more patients experiencing a range of unexpected oral side effects

Koopen A, Witjes J, Wortelboer K, Majait S, Prodan A, Levin E, Herrema H, Winkelmeijer M, Aalvink S, Bergman J, et al

For some individuals, a subtle reduction in cravings and early satiety (feeling full faster) can be felt within the first two to three days

The Precision Peptide Genetic Test ($99 add-on after your first month) identifies whether your genetic variants in GLP1R (rs6923761), GIPR (rs1800437), or MC4R (rs17782313) predict higher or lower sensitivity to GLP-1 effects, including gastrointestinal side effects